Redwood AI Announces Platform Name Change and Appointment of Dr. Mark Dybul as Public Safety & Defense Advisor

VANCOUVER, BC / ACCESS Newswire / March 13, 2026 / Redwood AI Corp. (CSE:AIRX)(Frankfurt:Y0N, WKN: A422EZ) ("Redwood" or the "Company") is pleased to announce a name change to its proprietary AI-powered chemical synthesis platform. The platform, formerly known as ‘SythesAltzer', has been renamed Reactosphere (the "Software" or "Platform"), a name chosen to reflect the Platform's evolution beyond synthesis route generation into a more advanced intelligence system capable of supporting applications across multiple industries.

Originally developed to apply artificial intelligence and machine learning to complex chemical synthesis and reaction modeling, the Platform has evolved into a broader architecture designed to support advanced chemistry applications across multiple industries, including life sciences, healthcare, public safety, biosecurity, and strategic defense-related technologies. The Platform integrates chemical intelligence, data-driven modeling, and scalable computational tools designed to assist organizations in addressing complex scientific and operational challenges.

As Redwood works to expand the strategic applications of its Platform across areas including public safety, biosecurity, and defense-related technologies, the Company is also pleased to announce the appointment of Dr. Mark R. Dybul as Public Safety & Defense Advisor to the Company.

Dr. Dybul is a physician, scientist, and internationally recognized public health leader with more than two decades of experience in infectious disease research, global health policy, and large-scale healthcare program implementation. He served as United States Global AIDS Coordinator under President George W. Bush, where he led the implementation of the President's Emergency Plan for AIDS Relief (PEPFAR), one of the largest international health initiatives in history.^[1]

Dr. Dybul held the rank of Rear Admiral in the U.S. Public Health Service and served as Assistant U.S. Surgeon General^[2], reflecting his leadership in national and global public health initiatives. He later served as Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, one of the world's largest international health financing organizations dedicated to combating infectious diseases. Dr. Dybul is currently a Professor of Medicine at Georgetown University and has spent more than 25 years working as a clinician, researcher, and global health leader addressing infectious diseases, health systems development, and international health policy.^[3]